Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Babal K Jha

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
Seminars in Hematology|January 29, 2021
Epigenetic modifier directed therapeutics to unleash healthy genes in unhealthy cellsBabal K Jha, Yogen Saunthararajah
Seminars in Hematology|March 2, 2024
TET2 mutation as prototypic clonal hematopoiesis lesionLuca Guarnera, Babal K Jha
Oncotarget|April 23, 2019
<i>TET2</i> mutations and clonal dynamicsAshwin Kishtagari, Babal K Jha, Jaroslaw P Maciejewski
Oncotarget|June 26, 2014
Mode and specificity of binding of the small molecule GANT61 to GLI determines inhibition of GLI-DNA bindingAkwasi Agyeman, Babal K Jha, Tapati Mazumdar, et al.
RNA Biology|December 18, 2008
A putative loop E motif and an H-H kissing loop interaction are conserved and functional features in a group C enterovirus RNA that inhibits ribonuclease LHannah L Townsend, Babal K Jha, Robert H Silverman, et al.
Seminars in Hematology|January 29, 2021
TET-dioxygenase deficiency in oncogenesis and its targeting for tumor-selective therapeuticsYihong Guan, Metis Hasipek, Anand D Tiwari, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 5, 2013
Suppression of antiviral innate immunity by sunitinib enhances oncolytic virotherapyBabal K Jha, Beihua Dong, Carvell T Nguyen, et al.
Nucleic Acids Research|August 5, 2011
Nucleoside modifications in RNA limit activation of 2'-5'-oligoadenylate synthetase and increase resistance to cleavage by RNase LBart R Anderson, Hiromi Muramatsu, Babal K Jha, et al.
Nucleic Acids Research|February 7, 2014
Ribonuclease L and metal-ion-independent endoribonuclease cleavage sites in host and viral RNAsDaphne A Cooper, Babal K Jha, Robert H Silverman, et al.
Bioorganic & Medicinal Chemistry|April 24, 2021
SAR insights into TET2 catalytic domain inhibition: Synthesis of 2-Hydroxy-4-Methylene-pentanedicarboxylatesAnand D Tiwari, Yihong Guan, Dale R Grabowski, et al.
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Seminars in Hematology|January 29, 2021
Epigenetic modifier directed therapeutics to unleash healthy genes in unhealthy cellsBabal K Jha, Yogen Saunthararajah
Seminars in Hematology|March 2, 2024
TET2 mutation as prototypic clonal hematopoiesis lesionLuca Guarnera, Babal K Jha
Oncotarget|April 23, 2019
<i>TET2</i> mutations and clonal dynamicsAshwin Kishtagari, Babal K Jha, Jaroslaw P Maciejewski
Oncotarget|June 26, 2014
Mode and specificity of binding of the small molecule GANT61 to GLI determines inhibition of GLI-DNA bindingAkwasi Agyeman, Babal K Jha, Tapati Mazumdar, et al.
RNA Biology|December 18, 2008
A putative loop E motif and an H-H kissing loop interaction are conserved and functional features in a group C enterovirus RNA that inhibits ribonuclease LHannah L Townsend, Babal K Jha, Robert H Silverman, et al.
Seminars in Hematology|January 29, 2021
TET-dioxygenase deficiency in oncogenesis and its targeting for tumor-selective therapeuticsYihong Guan, Metis Hasipek, Anand D Tiwari, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 5, 2013
Suppression of antiviral innate immunity by sunitinib enhances oncolytic virotherapyBabal K Jha, Beihua Dong, Carvell T Nguyen, et al.
Nucleic Acids Research|August 5, 2011
Nucleoside modifications in RNA limit activation of 2'-5'-oligoadenylate synthetase and increase resistance to cleavage by RNase LBart R Anderson, Hiromi Muramatsu, Babal K Jha, et al.
Nucleic Acids Research|February 7, 2014
Ribonuclease L and metal-ion-independent endoribonuclease cleavage sites in host and viral RNAsDaphne A Cooper, Babal K Jha, Robert H Silverman, et al.
Bioorganic & Medicinal Chemistry|April 24, 2021
SAR insights into TET2 catalytic domain inhibition: Synthesis of 2-Hydroxy-4-Methylene-pentanedicarboxylatesAnand D Tiwari, Yihong Guan, Dale R Grabowski, et al.
Pageof 5